i
Update on Moderna’s RSV Vaccine, mRESVIA (mRNA-1345), in Adults ≥60 Years of Age
-
June 26, 2024
Details:
-
Personal Author:
-
Corporate Authors:
-
Conference Authors:
-
Description:04-RSV-Adult-Das-508.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:urn:sha256:651436acbfa98825f6620f4aede80518789b06b40b9e6c25bd74844dabcc38bc
-
Download URL:
-
File Type:
Related Documents
-
- Personal Author:Bergren, NicholasJune 26, 2024 | ACIP meeting Respiratory Syncytial Virus Vaccines – AdultDescription:Dengue Tetravalent Vaccine (Live, Attenuated) [Dengvaxia®] is being discontinued due to low demand.This decision is not due to any concerns regarding...Personal Author:Ortega-Sanchez, Ismael R.June 26, 2024 | ACIP meeting Respiratory Syncytial Virus Vaccines – AdultDescription:Evidence to Recommendations Framework (EtR) : RSV Vaccination in Adults Aged 50–59 years, 60–74 years, and 75 years and older